Literature DB >> 22441676

A single-amino-acid variant of the H60 CD8 epitope generates specific immunity with diverse TCR recruitment.

Su Jeong Ryu1, Ji Yeong Jeon, Jun Chang, Thomas J Sproule, Derry C Roopenian, Eun Young Choi.   

Abstract

TCR of CD8 T cells recognizes peptides of 8-9 amino acids in length (epitope) complexed with MHC class I. Peptide ligands differing from an epitope by one or two amino acids are thought to modulate the immune response specific to that epitope. H60 is a minor histocompatibility antigen for which the specific CD8 T-cell response dominates during alloresponse after MHC-matched allogeneic transplantation. In the present study, we developed a transgenic mouse (designated H60H Tg) expressing a variant of H60, designated H60H, in which the arginine residue at position 4 of the H60 epitope sequence (LTFNYRNL) is replaced by a histidine residue (LTFHYRNL). Immunization of female C57BL/6 mice with splenocytes from male H60H Tg induced a CD8 T cell primary response and memory response after re-challenge. The response was CD4 help-dependent, demonstrating the potency of H60H as a cellular antigen. The response induced by the H60H cellular antigen was comparable to that induced by H60 in its peak magnitude and overall immune kinetics. H60H challenge recruited broadly diverse TCRs to the specific response, shaping a TCR repertoire different from that of the natural H60 epitope. However, some of the TCRs did overlap between the H60H- and H60-specific CD8 T cells, suggesting that H60H might modulate the H60-specific response. These results may provide a basis for the modulation of the H60-specific CD8 T-cell response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22441676      PMCID: PMC3887807          DOI: 10.1007/s10059-012-0008-3

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  30 in total

1.  Possibilities and limitations in the rational design of modified peptides for T cell mediated immunotherapy.

Authors:  Ellen C de Haan; Ed E Moret; Josée P A Wagenaar-Hilbers; Rob M J Liskamp; Marca H M Wauben
Journal:  Mol Immunol       Date:  2005-02       Impact factor: 4.407

Review 2.  Polyspecificity of T cell and B cell receptor recognition.

Authors:  Kai W Wucherpfennig; Paul M Allen; Franco Celada; Irun R Cohen; Rob De Boer; K Christopher Garcia; Byron Goldstein; Ralph Greenspan; David Hafler; Philip Hodgkin; Erik S Huseby; David C Krakauer; David Nemazee; Alan S Perelson; Clemencia Pinilla; Roland K Strong; Eli E Sercarz
Journal:  Semin Immunol       Date:  2007-03-29       Impact factor: 11.130

Review 3.  A very high level of crossreactivity is an essential feature of the T-cell receptor.

Authors:  D Mason
Journal:  Immunol Today       Date:  1998-09

4.  Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon gamma by T cells.

Authors:  V Kumar; V Bhardwaj; L Soares; J Alexander; A Sette; E Sercarz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

5.  Evidence for a differential avidity model of T cell selection in the thymus.

Authors:  P G Ashton-Rickardt; A Bandeira; J R Delaney; L Van Kaer; H P Pircher; R M Zinkernagel; S Tonegawa
Journal:  Cell       Date:  1994-02-25       Impact factor: 41.582

6.  Immunodominance of H60 is caused by an abnormally high precursor T cell pool directed against its unique minor histocompatibility antigen peptide.

Authors:  Eun Young Choi; Gregory J Christianson; Yoshitaka Yoshimura; Thomas J Sproule; Nadja Jung; Sebastian Joyce; Derry C Roopenian
Journal:  Immunity       Date:  2002-11       Impact factor: 31.745

7.  Coronary artery disease from isolated non-H2-determined incompatibilities in transplanted mouse hearts.

Authors:  Paul S Russell; Catharine M Chase; Joren C Madsen; Tsutomu Hirohashi; Lynn D Cornell; Thomas J Sproule; Robert B Colvin; Derry C Roopenian
Journal:  Transplantation       Date:  2011-04-27       Impact factor: 4.939

8.  Effects of Pre-conditioning Dose on the Immune Kinetics and Cytokine Production in the Leukocytes Infiltrating GVHD Tissues after MHC-matched Transplantation.

Authors:  Jung Hwa Choi; Hyewon Yoon; Chang-Ki Min; Eun Young Choi
Journal:  Immune Netw       Date:  2011-02-28       Impact factor: 6.303

9.  Characterization of CTL Clones Specific for Single Antigen, H60 Minor Histocompatibility Antigen.

Authors:  Ji Yeong Jeon; Kyung Min Jung; Jun Chang; Eun Young Choi
Journal:  Immune Netw       Date:  2011-04-30       Impact factor: 6.303

10.  Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: more than blocking alone.

Authors:  M H Wauben; C J Boog; R van der Zee; I Joosten; A Schlief; W van Eden
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

View more
  2 in total

Review 1.  H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect.

Authors:  Eun Young Choi; Kyungho Choi; Giri Nam; Woojin Kim; Minho Chung
Journal:  Front Immunol       Date:  2020-06-10       Impact factor: 7.561

2.  Selection of Thymocytes Expressing Transgenic TCR Specific for a Minor Histocompatibility Antigen, H60.

Authors:  Ji-Min Ju; Min Bum Kim; Su Jeong Ryu; Joo Young Kim; Jun Chang; Eun Young Choi
Journal:  Immune Netw       Date:  2015-10-26       Impact factor: 6.303

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.